Paper40263271
Structure of a lasso peptide bound ETB receptor provides insights into the mechanism of GPCR inverse agonism.
Shihoya W and 12 others. Nat Commun, 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Structure of a lasso peptide bound ETB receptor provides insights into the mechanism of GPCR inverse agonism. Papers, record 40263271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40263271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Structure of a lasso peptide bound ETB receptor provides insights into the mechanism of GPCR inverse agonism.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Receptor, Endothelin B | Major topic |
| Peptides | Major topic |
| Receptors, G-Protein-Coupled | Major topic |
| Humans | |
| Cryoelectron Microscopy | |
| Protein Binding | |
| Drug Inverse Agonism | |
| Structure-Activity Relationship | |
| Protein Conformation | |
| Models, Molecular | |
| HEK293 Cells |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 21H05037 | MEXT | Japan Society for the Promotion of Science (JSPS) | PubMed | ||
| JP233fa627001 | Japan Agency for Medical Research and Development (AMED) | PubMed | ||
| JP23ama121002 | Japan Agency for Medical Research and Development (AMED) | PubMed | ||
| JP23ama121012 | Japan Agency for Medical Research and Development (AMED) | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23884378 | Endothelin 1 in cancer: biological implications and therapeutic opportunities. | Nat Rev Cancer | 2013 | https://conductscience.org/library/papers/23884378 | PubMed |
| 2 | 33823110 | Cell-Free Biosynthesis to Evaluate Lasso Peptide Formation and Enzyme-Substrate Tolerance. | J Am Chem Soc | 2021 | https://conductscience.org/library/papers/33823110 | PubMed |
| 3 | 20124702 | PHENIX: a comprehensive Python-based system for macromolecular structure solution. | Acta Crystallogr D Biol Crystallogr | 2010 | https://conductscience.org/library/papers/20124702 | PubMed |
| 4 | 30412051 | New tools for automated high-resolution cryo-EM structure determination in RELION-3. | Elife | 2018 | https://conductscience.org/library/papers/30412051 | PubMed |
| 5 | 27595334 | Activation mechanism of endothelin ETB receptor by endothelin-1. | Nature | 2016 | https://conductscience.org/library/papers/27595334 | PubMed |
| 6 | 9568909 | Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms. | Protein Sci | 1998 | https://conductscience.org/library/papers/9568909 | PubMed |
| 7 | 31591578 | Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. | Nat Methods | 2019 | https://conductscience.org/library/papers/31591578 | PubMed |
| 8 | 37491722 | Structural insights into endothelin receptor signalling. | J Biochem | 2023 | https://conductscience.org/library/papers/37491722 | PubMed |
| 9 | 7543369 | X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. | Cell | 1995 | https://conductscience.org/library/papers/7543369 | PubMed |
| 10 | 33117783 | Lasso Peptides: Heterologous Production and Potential Medical Application. | Front Bioeng Biotechnol | 2020 | https://conductscience.org/library/papers/33117783 | PubMed |
| 11 | 26079760 | Lasso peptides: an intriguing class of bacterial natural products. | Acc Chem Res | 2015 | https://conductscience.org/library/papers/26079760 | PubMed |
| 12 | 7733942 | Species difference in the binding characteristics of RES-701-1: potent endothelin ETB receptor-selective antagonist. | Biochem Biophys Res Commun | 1995 | https://conductscience.org/library/papers/7733942 | PubMed |
| 13 | 22833149 | Lasso peptides: structure, function, biosynthesis, and engineering. | Nat Prod Rep | 2012 | https://conductscience.org/library/papers/22833149 | PubMed |
| 14 | 28805809 | X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog. | Nat Struct Mol Biol | 2017 | https://conductscience.org/library/papers/28805809 | PubMed |
| 15 | 39565314 | Calcineurin-fusion facilitates cryo-EM structure determination of a Family A GPCR. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39565314 | PubMed |
| 16 | 27038509 | Thermostabilization of the Human Endothelin Type B Receptor. | J Mol Biol | 2016 | https://conductscience.org/library/papers/27038509 | PubMed |
| 17 | 28165473 | cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. | Nat Methods | 2017 | https://conductscience.org/library/papers/28165473 | PubMed |
| 18 | 23535598 | Structural basis for the drug extrusion mechanism by a MATE multidrug transporter. | Nature | 2013 | https://conductscience.org/library/papers/23535598 | PubMed |
| 19 | 38498911 | Cryo-EM advances in GPCR structure determination. | J Biochem | 2024 | https://conductscience.org/library/papers/38498911 | PubMed |
| 20 | 37096326 | Cryo-EM structure of the endothelin-1-ETB-Gi complex. | Elife | 2023 | https://conductscience.org/library/papers/37096326 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42334221 | Tangled Tail of Mechanically Interlocked Peptides. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/42334221 | PubMed |
| 41959090 | De novo Folding Mechanisms of Lasso Peptides. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959090 | PubMed |
| 41507421 | Strategic advances for cryo-EM structural studies of small (<100 kDa) GPCRs. | Commun Biol | 2026 | https://conductscience.org/library/papers/41507421 | PubMed |
| 39261643 | Substrate interactions guide cyclase engineering and lasso peptide diversification. | Nat Chem Biol | 2025 | https://conductscience.org/library/papers/39261643 | PubMed |
| 39218755 | Advances in lasso peptide discovery, biosynthesis, and function. | Trends Genet | 2024 | https://conductscience.org/library/papers/39218755 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EDNRB | 1910 | PubTator's text mining | https://conductscience.org/library/genes/1910 | NCBI Gene |
| VN1R17P | 441931 | PubTator's text mining | https://conductscience.org/library/genes/441931 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40263271
GET https://conductscience.org/api/papers/v1/40263271/references?page=2